The creation of DF/HCC has significantly enhanced efforts to obtain funding of multi-investigator grants. In turn, work supported by these grants has helped to spark new collaborations among Program members. Examples of such grants include:
| Grant# | Grant Title | Principal Investigator | Institution | Project List | Number of institutions involved |
| UO1-CA62490 | Phase I Trials of New Anti-Cancer Agents | Donald Kufe | DFCI | Conduct Phase I, I-II pharmacokinetic /pharmacodynamic trials of new cytotoxic agents, signal transduction inhibitors, differentiating agents and angiogenesis inhibitors, with correlative laboratory and imaging studies to define biological endpoints and mechanisms. | DFCI MGH BIDMC BWH CHB |
| R21-CA101712 | Overcoming Barriers to Minority Recuritment to Clinical Trials | Bruce Chabner | MGH | The purpose of this grant is to develop new approaches to the recruitment of minority patients to clinical trials. The grant has completed its first year with 26 patients referred and 5 on active treatment. | MGH DFCI BIDMC BWH |
| P50-CA100707 | Myeloma SPORE | Kenneth Anderson | DFCI | Project: Kufe. MUC1 as a therapeutic target in multiple myeloma. | DFCI BIDMC HMS |
| P50-CA101942 | Renal SPORE | Micheal Atkins | BIDMC | Project: Kufe/Avigan. Dendritic cell/tumor fusions in conjunction with IL-12 as novel immunotherapy for renal cancer. | DFCI BIDMC MGH |
| P50-CA105009 | Ovarian Cancer SPORE | Daniel Cramer | BWH | Project: Kufe. Novel immunotherapeutic approaches for ovarian cancer. | DFCI BIDMC MGH BWH |
| P50-CA93683 | Skin Cancer SPORE | Thomas Kupper | BWH | Project: Kufe/Avigan. Direct comparison of dendritic cell vaccines in melanoma. | DFCI BIDMC MGH BWH |
| PO1-CA78378 | Myeloma PO-1 | Kenneth Anderson | DFCI | Project: Kufe/Avigan. Development of myeloma vaccines. | DFCI BIDMC |
| PO1-CA6848 | ALL PO-1 | Stephen Sallan | DFCI | Project: Kufe/Supko. Therapeutic index of ALL. | DFCI MGH CHB |
| UO1-CA105689 | NABTT | Tracy Batchelor | MGH | Project: Supko. Pharmacokinetics. | MGH |
| DAMD-03-1-0487 | DOD Breast Cancer Grant | Donald Kufe | DFCI | Fusions of breast carcinoma and dendritic cells as a vaccine for the treatment of metastatic breast cancer. | DFCI BIDMC MGH |